KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Receivables (2016 - 2025)

Historic Receivables for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $60.1 million.

  • Staar Surgical's Receivables fell 4248.88% to $60.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.1 million, marking a year-over-year decrease of 4248.88%. This contributed to the annual value of $105.4 million for FY2024, which is 1110.07% up from last year.
  • As of Q3 2025, Staar Surgical's Receivables stood at $60.1 million, which was down 4248.88% from $34.4 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Receivables ranged from a high of $112.4 million in Q3 2023 and a low of $33.7 million during Q2 2021
  • Moreover, its 5-year median value for Receivables was $61.3 million (2022), whereas its average is $65.0 million.
  • As far as peak fluctuations go, Staar Surgical's Receivables skyrocketed by 10272.24% in 2023, and later plummeted by 6328.36% in 2025.
  • Staar Surgical's Receivables (Quarter) stood at $43.6 million in 2021, then skyrocketed by 43.21% to $62.5 million in 2022, then surged by 51.9% to $94.9 million in 2023, then grew by 11.07% to $105.4 million in 2024, then plummeted by 42.97% to $60.1 million in 2025.
  • Its last three reported values are $60.1 million in Q3 2025, $34.4 million for Q2 2025, and $39.9 million during Q1 2025.